Decheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. Founded in 2012, Decheng continues to capitalize on a historic opportunity in the rapid growth of the healthcare industry as well as breakthroughs in life science research. With over $2 billion in capital, Decheng is poised to create value for our investors and entrepreneur partners.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions